For zoonotic diseases, an increasingly mobile global population may lead to closer proximity with reservoir populations. Our goal is to address these evolving risks by providing vaccines against global threats. Currently, we commercialise vaccines for rabies and tick-borne encephalitis (TBE) – to protect your patients at home and abroad. In Finland we have marketing authorization for the TBE vaccine Encepur and therefore this site focuses on it. More information on rabies and rabies prevention you can find from THL's webpage.